Program to improve sleep and reduce suicidal behavior in adolescents
Official title: Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Run by Nationwide Children's Hospital · NCT05390918 · Data updated 2026-11-12
This study is testing a new program to help teenagers who have trouble sleeping and are feeling suicidal, to see if it can improve their sleep and reduce their suicidal thoughts.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years to 18 Years |
| Sex | All |
| Enrollment | 235 (estimated) |
| Sponsor | Nationwide Children's Hospital Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | October 20, 2022 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT05390918 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 11 to 18 who have experienced recent suicidal ideation and sleep problems.
✕Probably not a fit
Patients who have attempted suicide in the past three months or have certain psychiatric diagnoses will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests the TAILOR program, which aims to improve sleep and reduce suicidal ideation in adolescents facing sleep difficulties and recent suicidal thoughts. The intervention combines Cognitive Behavioral Therapy, Motivational Interviewing, and remote support to address both sleep issues and suicidal risk. Participants will be compared to a control group receiving Enhanced Usual Care to evaluate the effectiveness of TAILOR over a period of four months.
Why it matters
Potential benefit: If successful, this program could significantly reduce sleep problems and suicidal thoughts in adolescents, improving their overall mental health.
How similar studies have gone: Other studies have shown promise in using behavioral interventions for sleep and suicide prevention, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion: * Nationwide Children's Hospital patients * Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent * Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days) * Resides with primary caregiver who has legal authority to consent to research participation Exclusion: * Suicide attempt in the past 3 months * Diagnosis of Bipolar Disorder or Psychosis * Having a change to an antipsychotic and/or mood stabilizer medication regimen within the last 2 months * Snoring at least 3 nights per week that can be heard a room or two away, even without a cold or flu or during allergy season * Gasping for air while sleeping, diagnosis of Obstructive Sleep Apnea, or turning blue within the past year * Body Mass Index \> 40 * Daytime symptoms of Restless Leg Syndrome * Diagnosis of Narcolepsy * Diagnosis of Seizures or Epilepsy, or prescribed anticonvulsant medication, within the past 4 years * Significant substance use in the past month * Currently receiving sleep disorder services from a sleep clinic * Inability to speak/read English adequately to understand and complete study consent and procedures * No access to a telephone or internet-connecting device * Sibling already in the study
Where it's running
-
Nationwide Children's Hospital
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Jeff Bridge, Ph.D. — Nationwide Children's Hospital
- Study coordinator: Elizabeth Cannon, MA, MS
- Email: elizabeth.cannon@nationwidechildrens.org
- Phone: 614-355-0578
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Mindfulness-based programs for suicidal thoughts and self-harm in Korean youth
We will test whether two mindfulness-based programs for Korean adolescents and young adults reduce suicidal thoughts, self-harm, depression, and problems with sleep and emotion regulation.
-
Youth suicide risk factors and personalized reduction strategies in young adults
This study tests whether combining clinical data, genetic information, neuroimaging, and microbiome data can help identify risk factors and see if a dTMS-based intervention reduces suicide risk in young adults with mood disorders.
-
SAFETY family-based program for youths after a suicide attempt
This project will test whether the SAFETY family-based therapy helps 10-17-year-olds who recently attempted suicide avoid repeat attempts.
-
Improving coping to reduce suicide risk after ED discharge
This study tests whether an electronic safety plan and supportive text messages can help adults who have recently had suicidal thoughts or behaviors after leaving the emergency department.
-
Intensive Crisis Intervention for teens with suicidal thoughts or behaviors
This project will try a brief, family-focused Intensive Crisis Intervention to see if it helps 12–17-year-olds with suicidal thoughts or recent attempts reduce suicidal behavior and avoid inpatient psychiatric care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.